Kotak Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.7%)Nav, as on 19-09-2024

  • Previous Nav

  • Net Change on 19-09-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 46.95 18.14 29.59 1.80 8,647.95
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 59.15 21.91 32.10 1.93 4,807.86
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 47.92 20.76 30.01 1.96 3,202.66
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 53.25 19.29 31.96 1.94 2,934.17
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 48.61 17.46 30.42 1.93 2,758.76

Fund Holdings as on 31-August-2024

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Divis Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Dr.Reddy's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Marksans Pharma Ltd

  • Alkem Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Glenmark Pharmaceuticals Ltd

  • JUBILANT PHARMOVA LIMITED

  • Ajanta Pharma Ltd.

  • INNOVA CAPTABS LTD

  • Lupin Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • KRISHNA INSTITUTE OF MEDICAL

  • Fortis Healthcare India Ltd

  • Metropolis Healthcare Ltd.

  • Glaxosmithkline Pharma Ltd

  • EMCURE PHARMACEUTICALS LIMITED

  • Triparty Repo

  • Biocon Ltd.

  • Ami Organics Ltd

  • GPT HEALTHCARE LIMITED

  • Alembic Pharmaceuticals Ltd.

  • Narayana Hrudalaya Ltd

  • Laurus Labs Ltd

  • Net Current Assets/(Liabilities)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

  • Education:B. Tech, M.Tech, PGDM
  • Experience:17
  • Basic Details:Mr. Dhananjay Tikariha has overall 17 years of experience in Equity Research, Fund Management and Project Finance. Prior to joining KMAMC, he has also worked at IDFC Ltd.
  • Funds Managed:
  • Kotak Healthcare Fund

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹374.57 crore. Kotak Healthcare Fund is benchmarked against Nifty Healthcare Index - TRI as primary index.

The NAV of Kotak Healthcare Fund ended down ₹-0.1(-0.7%)yesterday to ₹13.731.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455